No results, please enter a search term above
The Health Department has developed a webpage to help you track the number of mpox cases and vaccine availability in Philadelphia. This webpage will be updated every Monday.
|Date of Alert|
|No Health Alerts Found|
|Update on Managing Monkeypox in Patients Receiving Therapeutics||Update||Nov 21, 2022|
|Monkeypox Updates: Testing, Treatment, and Vaccine Updates||Update||Nov 4, 2022|
|Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions||Advisory||Oct 4, 2022|
|Jynneos Eligibility Update||Update||Sep 1, 2022|
|Tecovirimat Treatment for Monkeypox||Update||Aug 22, 2022|
Clinical presentation in the current outbreak has been atypical and often there is no prodrome. All patients have been found to have a skin rash upon physical examination, however the rash is often not scattered and is instead limited to one body site. Lymphadenopathy has not been universal during the current outbreak.
Key epidemiologic risk factors have included (1) contact with a person or people with a similar appearing rash or a diagnosis of mpox and (2) close or intimate contact with people in a social network experiencing mpox activity (e.g., men who have sex with men and transgender persons who have sex with men who meet partners through an online website, digital app, or social event).
Worldwide Surveillance Data from the CDC
Any patient who feels that they are at risk for coming into contact with mpox can now be vaccinated. No additional eligibility criteria need to be met.
Outreach should continue to those who are most at risk, including gay, bisexual, transgender, or other men who have sex with men and/or transgender, gender non-conforming, or non-binary persons who meet the following criteria:
Additionally, anyone with known close contact (skin-to-skin) with someone with mpox in the past 14 days should be vaccinated immediately.
More information on Philadelphia's mpox response can be found on the City of Philadelphia's webpage.
The following should be considered for management of suspected cases:
Healthcare workers using appropriate personal protective equipment (gown, gloves, N95 or surgical mask, and eye protection) should collect lesion specimens with sterile non-cotton swabs. Swabs sent to commercial labs should be sent in viral transport media. It is not necessary or recommended to unroof, open or aspirate mpox lesions with sharps to increase sample yield. Healthcare workers have acquired mpox after needle sticks from sharps used in specimen collection. For additional information on specimen collection and testing, see: Mpox Virus Testing Procedures For Labs
Regarding treatment of suspected and confirmed cases:
There are no patient or community resources for Mpox.
There are no posters for Mpox.